Cancer chemotherapy-induced nausea and vomiting have been demonstrated to involve humoral as well as neuronal mechanisms. A leading role of serotonin (5-hydroxytryptamine, 5-HT) in these mechanisms is supported by inhibition of the emesis by 5-HT 3 receptor antagonists. We compared the effects of granisetron, a selective 5-HT 3 receptor antagonist, and vagotomy on c-fos mRNA expression in the nucleus of the solitary tract (NTS) and the area postrema (AP) of the rat caudal brainstem by means of in situ hybridization. The expression of c-fos mRNA in the NTS and AP was signifi cantly elevated 2 h after cisplatin administration. The induction of c-fos expression by cisplatin in the NTS was signifi cantly inhibited by pretreatment with granisetron. In contrast, the c-fos expression in the AP did not differ between the cisplatin group and the granisetron-treated cisplatin group. The degree of the induction of c-fos mRNA expression in both the AP and NTS was similar between the vagotomy and sham operation groups. Our results suggest that the expression of c-fos mRNA in the NTS may be specifi cally controlled by 5-HT 3 receptors and that nonspecifi c humoral factors, such as modulation of transcriptional activity, play an important role in c-fos expression in the AP after vagotomy.Neuronal sites and signal substances involved in cancer chemotherapy-induced nausea and vomiting have been identifi ed neurochemically (20). Serotonin type 3 receptor (5-HT 3 receptor) antagonists protect against emesis in experimental animal models as well as in cisplatin-treated patients with cancer (35). Autoradiographic studies of 5-HT in the central nervous system showed that binding sites with the strongest affi nity for 5-HT 3 receptors are located in the nucleus of the solitary tract (NTS) and the area postrema (AP) of the caudal brainstem (33).However, considerable evidence supports the hypothesis that cytotoxic drug-induced emesis is mediated by local 5-HT release in the intestinal wall (4,14,15,27,28). 5-HT has a potent depolarizing action on the vagal afferent nerve (18,34). It has been proposed that anticancer drugs cause 5-HT release from enterochromaffin (EC) cells to activate the 5-HT 3 receptors on the afferent vagal nerve fi bers (1,26). These afferent fi bers may project to the dorsal vagal complex, which also expresses 5-HT 3 receptors on its central terminals (20,33). The vomiting center receives input from the afferent vagal fi bers to evoke an emetic refl ex (1,20). The vagus is the major nerve involved in the detection of emetic stimuli, and the abdominal vagus contains approximately 80-90% of the afferent fi bers (3). Electrical